Aditxt, Inc. (ADTX) vs GRI Bio, Inc. (GRI)

Aditxt, Inc. and GRI Bio, Inc. are both Biotechnology companies. Aditxt, Inc. and GRI Bio, Inc. are of similar size ($4.6M and $4.4M). Aditxt, Inc. has negative trailing earnings, so its P/E is not meaningful; GRI Bio, Inc. trades at 0.0×. GRI Bio, Inc. has the higher net margin (0.00% vs −372,998.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, GRI Bio, Inc. leads on 6 and Aditxt, Inc. on 5.

Valuation

Metric ADTX GRI Biotechnology median
P/E n/m 0.03 7.88
P/S n/m n/m 11.47
P/B n/m 0.36 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.74 0.74
EV/Sales 65.38 n/m 10.73
Earnings yield 0.00% 3,640.53% (28.84%)
Free cash flow yield 0.00% (281.76%) (23.03%)

Profitability

Metric ADTX GRI Biotechnology median
Gross margin 20.28% 0.00% 65.16%
Operating margin (128,143.36%) 0.00% 0.00%
Net margin (372,998.60%) 0.00% 0.00%
Free cash flow margin (129,979.72%) 0.00% 0.00%
Return on equity 549.59% (142.02%) (57.72%)
Return on assets (236.38%) (113.27%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ADTX GRI Biotechnology median
Revenue growth (TTM) (74.19%) — 5.64%
EPS growth (last fiscal year) 99.99% 92.12% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ADTX GRI Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.06 10.30 4.73
Net debt to EBITDA 0.18 0.69 0.96

Dividend

Metric ADTX GRI Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ADTX GRI Biotechnology median
Market cap 4.39m 4.57m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack